355 results on '"Torresi J"'
Search Results
2. Immune imprinting of SARS-CoV-2 responses: changing first immune impressions
3. Prevention of Hepatitis C Virus Infection and Liver Cancer
4. Adenovirus vector produced Zika virus-like particles induce a long-lived neutralising antibody response in mice
5. Prevention of Hepatitis C Virus Infection and Liver Cancer
6. Pre-clinical evaluation of a quadrivalent HCV VLP vaccine in pigs following microneedle delivery
7. Air-Liquid-Interface Differentiated Human Nose Epithelium: A Robust Primary Tissue Culture Model of SARS-CoV-2 Infection
8. A Complementary Union of SARS-CoV2 Natural and Vaccine Induced Immune Responses
9. Association between Severe Pandemic 2009 Influenza A (H1N1) Virus Infection and Immunoglobulin G 2 Subclass Deficiency
10. Analysis of two-proton transfer in the Ca 40 ( O 18
11. The Potential for Airborne Transmission of SARS-CoV-2 in Sport: A Cricket Case Study
12. Vaccine-induced immune thrombosis and thrombocytopenia syndrome following adenovirus-vectored severe acute respiratory syndrome coronavirus 2 vaccination: a novel hypothesis regarding mechanisms and implications for future vaccine development
13. Clinical stage drugs targeting inhibitor of apoptosis proteins purge episomal Hepatitis B viral genome in preclinical models
14. Incidence and seroprevalence of dengue virus infections in Australian travellers to Asia
15. Association between severe pandemic 2009 influenza A (H1N1) virus infection and immunoglobulin G2 subclass deficiency
16. Angiotensin converting enzyme 2 (ACE2) gene therapy using a high efficiency and liver-specific adeno-associated viral vector attenuates experimental liver fibrosis in mice
17. Increasing rates and clinical consequences of nalidixic acid-resistant isolates causing enteric fever in returned travellers: an 18-year experience
18. Optimization of the microwave-assisted extraction 185 (MAE) of the Cannabis sativa inflorescences to get a CBD-rich essential oil
19. Prevention of Hepatitis C Virus Infection and Liver Cancer
20. The Australasian COVID-19 Trial (ASCOT) to assess clinical outcomes in hospitalised patients with SARS-CoV-2 infection (COVID-19) treated with lopinavir/ritonavir and/or hydroxychloroquine compared to standard of care: A structured summary of a study protocol for a randomised controlled trial
21. Exploring the role of a recently licensed dengue vaccine in Australian travellers
22. Suboptimal SARS-CoV-2-specific CD8+ T cell response associated with the prominent HLA-A*02:01 phenotype
23. Cyclosporine, tacrolimus, sirolimus & mycophenolate enhance hepatitis C-induced hepatocyte apoptosis
24. A PHASE I CLINICAL TRIAL OF CELLULAR IMMUNOTHERAPY FOR PERSISTENT HEPATITIS C INFECTION: P07-02
25. Hepatitis C and cyclosporine reduce viability and induce apoptosis in liver cells
26. Incidence of influenza, dengue and Japanese encephalitis in Australian travellers visiting South and south-eastern Asia: O46
27. Isolated Core Antibody Hepatitis B in Sub-Saharan African Immigrants
28. Manual of Travel Medicine Fourth Edition
29. Cutaneous melioidosis: a review of the literature
30. A Hepatitis C Virus DNA Vaccine Encoding a Secreted, Oligomerized Form of Envelope Proteins Is Highly Immunogenic and Elicits Neutralizing Antibodies in Vaccinated Mice
31. Pre-clinical evaluation of a quadrivalent HCV VLP vaccine in pigs following microneedle delivery
32. ENHANCED REPLICATION OF HEPATITIS B VIRUS POLYMERASE MUTANT UNDER LAMIVUDINE TREATMENT FOLLOWING ANTIVIRAL TREATMENT AND LIVER TRANSPLANTATION
33. SIGNIFICANCE OF ENVELOPE PROTEIN VARIANTS OF HEPATITIS B VIRUS SELECTED BY TREATMENT WITH ANTIVIRAL NUCLEOSIDE ANALOGUES
34. Business travel-associated illness: a GeoSentinel analysis
35. HIV infection of hepatitis B virus (HBV)-infected hepatocytes increases CXCL10 production and is associated with liver fibrosis in HIV-HBV co-infected individuals
36. Animal-Associated Exposure to Rabies Virus among Travelers, 1997–2012
37. Immunological responses following administration of a genotype 1a/1b/2/3a quadrivalent HCV VLP vaccine
38. Large scale production of a mammalian cell derived quadrivalent hepatitis C virus like particle vaccine
39. Immunological responses following administration of a genotype 1a/1b/2/3a quadrivalent HCV VLP vaccine
40. Travel-associated Illness Trends and Clusters, 2000–2010
41. Preclinical Development and Production of Virus-Like Particles As Vaccine Candidates for Hepatitis C
42. The Rationale for a Preventative HCV Virus-Like Particle (VLP) Vaccine
43. Sex and Gender Differences in Travel‐Associated Disease
44. Vaccines licensed and in clinical trials for the prevention of dengue
45. Hepatitis C-induced hepatocyte apoptosis following liver transplantation is enhanced by immunosuppressive agents
46. Gastrointestinal infection among international travelers globally
47. Hepatitis C‐induced hepatocyte apoptosis following liver transplantation is enhanced by immunosuppressive agents
48. Effect of Immunosuppressive Agents on Hepatocyte Apoptosis Post-Liver Transplantation
49. Multicenter longitudinal study of diagnostic trends among returned travelers presenting to GeoSentinel sites, 2000-2010
50. Latitudinal patterns of travel among returned travelers with influenza: results fom the GeoSentinel Surveillance Network
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.